1107645-70-4

Basic information

• Product Name: N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-acetaMide
• Synonyms: N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-acetaMide
• CAS NO: 1107645-70-4
• Molecular Formula: C8H13ClN2O2
• Molecular Weight: 204.65402
• Mol File: 1107645-70-4.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 441.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.25±0.1 g/cm3(Predicted)
• PKA: 15?+-.0.20(Predicted)
• CAS DataBase Reference: N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-acetaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-acetaMide(1107645-70-4)
• EPA Substance Registry System: N-[(R)-1-(2-Chloro-acetyl)-pyrrolidin-3-yl]-acetaMide(1107645-70-4)

Safety Data

• Hazardous Substances Data: 1107645-70-4(Hazardous Substances Data)

Upstream product

• 79286-74-1 3-acetylaminopyrrolidine 
• 79-11-8 chloroacetic acid 

Relevant articles and documents

COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

The present invention discloses compounds according to Formula I: Wherein R1a, R1b, R2, R4, R5, R6a, R6b, R7, R8, W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseasesby administering the compound of the invention.